DK0642519T3 - Svovlholdige phosphonatforbindelser til behandling af unormal calcium- og phosphatmetabolisme - Google Patents
Svovlholdige phosphonatforbindelser til behandling af unormal calcium- og phosphatmetabolismeInfo
- Publication number
- DK0642519T3 DK0642519T3 DK93914151T DK93914151T DK0642519T3 DK 0642519 T3 DK0642519 T3 DK 0642519T3 DK 93914151 T DK93914151 T DK 93914151T DK 93914151 T DK93914151 T DK 93914151T DK 0642519 T3 DK0642519 T3 DK 0642519T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- sulfur
- phosphonate compounds
- phosphate metabolism
- abnormal calcium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/5532—Seven-(or more) membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/5765—Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89130992A | 1992-05-29 | 1992-05-29 | |
| PCT/US1993/004977 WO1993024496A1 (en) | 1992-05-29 | 1993-05-26 | Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0642519T3 true DK0642519T3 (da) | 2000-09-18 |
Family
ID=25397954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93914151T DK0642519T3 (da) | 1992-05-29 | 1993-05-26 | Svovlholdige phosphonatforbindelser til behandling af unormal calcium- og phosphatmetabolisme |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US5824661A (da) |
| EP (1) | EP0642519B1 (da) |
| JP (1) | JPH07507315A (da) |
| KR (1) | KR950701929A (da) |
| CN (2) | CN1061049C (da) |
| AT (1) | ATE195317T1 (da) |
| AU (1) | AU669372B2 (da) |
| CA (2) | CA2136818C (da) |
| CZ (1) | CZ296794A3 (da) |
| DE (1) | DE69329199D1 (da) |
| DK (1) | DK0642519T3 (da) |
| FI (1) | FI945593A0 (da) |
| HK (1) | HK1014002A1 (da) |
| HU (1) | HUT69699A (da) |
| IL (2) | IL105834A (da) |
| MX (1) | MX9303251A (da) |
| MY (1) | MY109736A (da) |
| NO (1) | NO305960B1 (da) |
| NZ (1) | NZ253524A (da) |
| PL (1) | PL175475B1 (da) |
| RU (1) | RU2136691C1 (da) |
| SG (1) | SG50518A1 (da) |
| SK (1) | SK144494A3 (da) |
| WO (1) | WO1993024496A1 (da) |
| ZA (1) | ZA933759B (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK144894A3 (en) * | 1992-05-29 | 1995-07-11 | Procter & Gamble Pharma | Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque |
| WO1993024500A1 (en) * | 1992-05-29 | 1993-12-09 | The Procter & Gamble Pharmaceuticals, Inc. | Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| TW401276B (en) * | 1993-10-07 | 2000-08-11 | Zeneca Ltd | Novel compounds and a method of controlling growth of plants |
| US5728650A (en) * | 1993-10-07 | 1998-03-17 | Zeneca Limited | Herbicidal aza bisphosphonic acids and compositions containing the same |
| US5646134A (en) * | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
| US6333424B1 (en) * | 1996-10-09 | 2001-12-25 | Eliza Nor Biopharmaceuticals, Inc. | Therapeutic derivatives of diphosphonates |
| US6121253A (en) * | 1998-11-20 | 2000-09-19 | Merck Frosst Canada & Co. | Prostaglandin conjugates for treating or preventing bone disease |
| FR2947266B1 (fr) * | 2009-06-26 | 2011-06-17 | Servier Lab | Nouveaux derives d'acide 2-mercaptocyclopentanecarboxylique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| TWI730039B (zh) * | 2016-01-29 | 2021-06-11 | 日商富士藥品股份有限公司 | 新穎雙膦酸化合物 |
| US11793452B2 (en) | 2019-10-03 | 2023-10-24 | Johnson & Johnson Consumer Inc. | Method of visualizing and quantifying remineralization |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3957858A (en) * | 1970-04-13 | 1976-05-18 | Monsanto Company | Substituted ethane diphosphonic acids and salts and esters thereof |
| US4208401A (en) * | 1977-08-19 | 1980-06-17 | Colgate-Palmolive Company | Quaternary ammonium alkylene diphosphonate anti-calculus agents |
| DE2745083C2 (de) * | 1977-10-07 | 1985-05-02 | Henkel KGaA, 4000 Düsseldorf | Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung |
| DE3016289A1 (de) * | 1980-04-28 | 1981-10-29 | Henkel KGaA, 4000 Düsseldorf | Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren |
| FR2531088B1 (fr) * | 1982-07-29 | 1987-08-28 | Sanofi Sa | Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation |
| US4642234A (en) * | 1983-09-15 | 1987-02-10 | University Of Bath | Disinfection of contact lenses |
| FR2558837B1 (fr) * | 1984-01-26 | 1986-06-27 | Sanofi Sa | Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant |
| DE3428524A1 (de) * | 1984-08-02 | 1986-02-13 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| US4687768A (en) * | 1984-12-21 | 1987-08-18 | The Procter & Gamble Company | Certain hexahydroindan-2,2-diphosphonic acids useful in treating diseases associated with abnormal calcium and phosphate metabolism |
| IL77243A (en) * | 1984-12-21 | 1996-11-14 | Procter & Gamble | Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds |
| US5104863A (en) * | 1984-12-21 | 1992-04-14 | The Procter & Gamble Company | Certain bicycloalkane and azabicycloalkane-1,1-diphosphonic acid derivatives useful for treating diseases associated with abnormal calcium and phosphate metabolism |
| US4902679A (en) * | 1985-12-13 | 1990-02-20 | Norwich Eaton Pharmaceuticals, Inc. | Methods of treating diseases with certain geminal diphosphonates |
| DE10199052I1 (de) * | 1986-11-21 | 2002-01-10 | Novartis Ag | Neue substituierte Alkandiphosphonsaeuren |
| DE3640938A1 (de) * | 1986-11-29 | 1988-06-01 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindung enthaltende arzneimittel |
| US5071840A (en) * | 1986-12-19 | 1991-12-10 | Norwich Eaton Pharmaceuticals, Inc. | Certain heterocyclic substituted diphosphonate compounds pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism |
| US4868164A (en) * | 1986-12-19 | 1989-09-19 | Norwich Eaton Pharmaceuticals, Inc. | Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism |
| IL86951A (en) * | 1987-07-06 | 1996-07-23 | Procter & Gamble Pharma | Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them |
| ATE90353T1 (de) * | 1987-12-11 | 1993-06-15 | Ciba Geigy Ag | Araliphatylaminoalkandiphosphonsaeuren. |
| US4933472A (en) * | 1988-04-08 | 1990-06-12 | Yamanouchi Pharmaceutical Co., Ltd. | Substituted aminomethylenebis(phosphonic acid) derivatives |
| TW198039B (da) * | 1988-11-28 | 1993-01-11 | Ciba Geigy Ag | |
| ATE91689T1 (de) * | 1989-04-03 | 1993-08-15 | Upjohn Co | Geminale bisphosphonsaeuren und deren derivate als antiarthritische mittel. |
| DE4011777A1 (de) * | 1989-04-14 | 1990-10-18 | Ciba Geigy Ag | N-trisubstituierte aminoalkandiphosphonsaeuren |
| US4922007A (en) * | 1989-06-09 | 1990-05-01 | Merck & Co., Inc. | Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof |
| EP0416689B1 (en) * | 1989-09-06 | 1995-11-29 | Merck & Co. Inc. | Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors |
| WO1991010646A1 (en) * | 1990-01-12 | 1991-07-25 | Rhone-Poulenc Rorer International (Holdings) Inc. | 1-azetidyl and 1-hexamethylenimine alkyl or aryl bisphosphonic acids and their use as pharmacological agents |
| ATE165603T1 (de) * | 1991-09-05 | 1998-05-15 | Toray Industries | Methandiphosphonsäurederivat, herstellung davon und verwendung davon als arzneimittel |
-
1993
- 1993-05-26 RU RU94046117A patent/RU2136691C1/ru active
- 1993-05-26 JP JP6500722A patent/JPH07507315A/ja active Pending
- 1993-05-26 CA CA002136818A patent/CA2136818C/en not_active Expired - Fee Related
- 1993-05-26 PL PL93306139A patent/PL175475B1/pl unknown
- 1993-05-26 AT AT93914151T patent/ATE195317T1/de not_active IP Right Cessation
- 1993-05-26 DE DE69329199T patent/DE69329199D1/de not_active Expired - Lifetime
- 1993-05-26 SK SK1444-94A patent/SK144494A3/sk unknown
- 1993-05-26 WO PCT/US1993/004977 patent/WO1993024496A1/en not_active Application Discontinuation
- 1993-05-26 NZ NZ253524A patent/NZ253524A/en unknown
- 1993-05-26 DK DK93914151T patent/DK0642519T3/da active
- 1993-05-26 EP EP93914151A patent/EP0642519B1/en not_active Expired - Lifetime
- 1993-05-26 CZ CZ942967A patent/CZ296794A3/cs unknown
- 1993-05-26 CA CA002188066A patent/CA2188066C/en not_active Expired - Fee Related
- 1993-05-26 KR KR1019940704307A patent/KR950701929A/ko active IP Right Grant
- 1993-05-26 HU HU9403408A patent/HUT69699A/hu unknown
- 1993-05-26 AU AU43917/93A patent/AU669372B2/en not_active Ceased
- 1993-05-26 SG SG1996003361A patent/SG50518A1/en unknown
- 1993-05-28 IL IL10583493A patent/IL105834A/en not_active IP Right Cessation
- 1993-05-28 MY MYPI93001056A patent/MY109736A/en unknown
- 1993-05-28 ZA ZA933759A patent/ZA933759B/xx unknown
- 1993-05-29 CN CN93108419A patent/CN1061049C/zh not_active Expired - Fee Related
- 1993-05-31 MX MX9303251A patent/MX9303251A/es not_active IP Right Cessation
-
1994
- 1994-09-07 US US08/301,514 patent/US5824661A/en not_active Expired - Fee Related
- 1994-11-24 NO NO944499A patent/NO305960B1/no not_active IP Right Cessation
- 1994-11-28 FI FI945593A patent/FI945593A0/fi unknown
-
1996
- 1996-11-19 IL IL11964896A patent/IL119648A0/xx unknown
-
1998
- 1998-12-21 HK HK98114257A patent/HK1014002A1/xx not_active IP Right Cessation
-
1999
- 1999-12-23 CN CN99127416A patent/CN1288008A/zh active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI864614A0 (fi) | Nya difosfonsyraderivat, foerfaranden foer framstaellning av dessa samt laekemedel innehaollande dessa foereningar. | |
| DK0579196T3 (da) | Glycolipidderivater | |
| DE69133299D1 (de) | Aminosulfonylcarbamate | |
| DK0642519T3 (da) | Svovlholdige phosphonatforbindelser til behandling af unormal calcium- og phosphatmetabolisme | |
| DE69132651T2 (de) | Schwefel enthaltende heterocyclische Verbindungen | |
| SE7706392L (sv) | N-fosfonometylenmonoaminoalkanmono- och -polyfosfonsyror respektive n-fosfonometylendiaminoalkanpolyfosfonsyror samt sett for deras framstellning | |
| DE68918827T2 (de) | Schwefel enthaltende heterocyclische Verbindungen. | |
| DE3575715D1 (de) | Adamantanamin-derivate, verfahren zur herstellung und diese enthaltende heilmittel. | |
| ES2074828T3 (es) | Copoliester degradable de 4-hidroxi-prolina y composicion farmaceutica que lo contiene. | |
| DK0904270T3 (da) | Dihydrobenzofuran og beslægtede forbindelser anvendelige som antiinflammatoriske midler | |
| DE3750891D1 (de) | Neue Thyroninderivate. | |
| ATE111947T1 (de) | Ferroelektrische chirale smektische flüssigkristallzusammensetzung und vorrichtung mit dieser zusammensetzung. | |
| TW330205B (en) | A process for preparing loracarbef monohydrate | |
| ATE142246T1 (de) | Chirale smektische flüssigkristallzusammensetzung und vorrichtung mit dieser zusammensetzung | |
| ATE120227T1 (de) | Ferroelektrische chirale smektische flüssigkristallzusammensetzung und vorrichtung mit dieser zusammensetzung. | |
| ES480969A1 (es) | Procedimiento para la aclaracion optica de materiales organicos, en especial de tipo textil. | |
| ES477355A1 (es) | Procedimiento para la preparacion de 4-pirimidilsulfuros. |